Previous studies have shown that FRS2 and FGFR are highly expressed and active in several high-grade liposarcomas, and targetable by the FGFR inhibitor NVP-BGJ398 in DDLPS cell lines in vitro [36]. This evidence concerns the gene FRS2 and liposarcoma.